Citigroup’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $499K | Sell |
11,866
-33,766
| -74% | -$1.42M | ﹤0.01% | 2933 |
|
|
2025
Q1 | $1.73M | Sell |
45,632
-49,415
| -52% | -$1.87M | ﹤0.01% | 2184 |
|
|
2024
Q4 | $7.31M | Buy |
95,047
+11,697
| +14% | +$900K | ﹤0.01% | 1151 |
|
|
2024
Q3 | $4.8M | Buy |
83,350
+75,739
| +995% | +$4.36M | ﹤0.01% | 1374 |
|
|
2024
Q2 | $315K | Sell |
7,611
-7,507
| -50% | -$310K | ﹤0.01% | 2954 |
|
|
2024
Q1 | $923K | Sell |
15,118
-8,406
| -36% | -$513K | ﹤0.01% | 2426 |
|
|
2023
Q4 | $524K | Buy |
23,524
+17,983
| +325% | +$401K | ﹤0.01% | 2659 |
|
|
2023
Q3 | $142K | Buy |
5,541
+5,529
| +46,075% | +$142K | ﹤0.01% | 3127 |
|
|
2023
Q2 | $214 | Sell |
12
-107
| -90% | -$1.91K | ﹤0.01% | 4667 |
|
|
2023
Q1 | $1.45K | Sell |
119
-18
| -13% | -$219 | ﹤0.01% | 4404 |
|
|
2022
Q4 | $4.89K | Sell |
137
-495
| -78% | -$17.7K | ﹤0.01% | 4302 |
|
|
2022
Q3 | $22K | Sell |
632
-15,606
| -96% | -$543K | ﹤0.01% | 3998 |
|
|
2022
Q2 | $597K | Buy |
16,238
+14,219
| +704% | +$523K | ﹤0.01% | 2464 |
|
|
2022
Q1 | $309K | Sell |
2,019
-3,359
| -62% | -$514K | ﹤0.01% | 3158 |
|
|
2021
Q4 | $1.59M | Buy |
5,378
+2,837
| +112% | +$838K | ﹤0.01% | 2141 |
|
|
2021
Q3 | $705K | Buy |
2,541
+81
| +3% | +$22.5K | ﹤0.01% | 2661 |
|
|
2021
Q2 | $674K | Sell |
2,460
-652
| -21% | -$179K | ﹤0.01% | 2869 |
|
|
2021
Q1 | $1.53M | Buy |
3,112
+2,966
| +2,032% | +$1.46M | ﹤0.01% | 2101 |
|
|
2020
Q4 | $120K | Buy |
+146
| New | +$120K | ﹤0.01% | 3563 |
|